13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 40 holding rows worth $610,879,430.
- Accession
- 0001193125-25-283112
- Filer
- CIK 1687078
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 40 entries on the cover page, a total value of $610,879,430 stated on the cover page (in dollars after the unit check, H1), rows summing to $610,879,430 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,415 | $46,056,344 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $45,354,229 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 760,022 | $33,114,159 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,406,955 | $31,173,638 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,720,741 | $27,910,419 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 438,477 | $26,909,333 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 745,060 | $25,250,083 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,375,674 | $21,164,744 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,729,378 | $20,752,536 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 341,496 | $20,295,107 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 503,398 | $20,211,430 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 789,698 | $18,557,903 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,446,361 | $18,296,467 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 5,075,970 | $17,765,895 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 549,262 | $16,477,860 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 563,075 | $16,362,960 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 98,924 | $15,923,796 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 614,282 | $15,013,052 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 315,722 | $14,744,217 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 14,705,882 | $14,247,058 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 700,000 | $13,489,000 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,303,399 | $13,099,160 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 3,903,381 | $12,725,022 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,282,680 | $11,915,590 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 395,700 | $11,902,656 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,505,262 | $11,018,518 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 1,054,504 | $10,545,040 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 150,000 | $10,140,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 1,634,569 | $10,085,291 | dollars as filed | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 2,889,125 | $7,887,311 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,408,810 | $4,745,356 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 200,000 | $4,548,000 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 67,423 | $4,226,748 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 555,187 | $4,180,558 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 380,000 | $3,883,600 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 530,299 | $3,621,942 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 135,000 | $2,693,250 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 71,807 | $2,132,668 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 819,924 | $1,443,066 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 39,665 | $1,015,424 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-25-283112 | this filing | 2025-11-14 | acceptance time not in the bulk data set |